X-13600018-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_015507.4(EGFL6):āc.324A>Gā(p.Arg108=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00475 in 1,208,191 control chromosomes in the GnomAD database, including 131 homozygotes. There are 1,546 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.022 ( 65 hom., 671 hem., cov: 21)
Exomes š: 0.0030 ( 66 hom. 875 hem. )
Consequence
EGFL6
NM_015507.4 synonymous
NM_015507.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.317
Genes affected
EGFL6 (HGNC:3235): (EGF like domain multiple 6) This gene encodes a member of the epidermal growth factor (EGF) repeat superfamily. Members of this superfamily are characterized by the presence of EGF-like repeats and are often involved in the regulation of cell cycle, proliferation, and developmental processes. The gene product contains a signal peptide, suggesting that it is secreted; an EGF repeat region consisting of 4 complete EGF-like repeats and 1 partial EGF-like repeat, 3 of which have a calcium-binding consensus sequence; an arg-gly-asp integrin association motif; and a MAM domain, which is believed to have an adhesive function. This gene is expressed early during development, and its expression has been detected in lung and meningioma tumors. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.53).
BP6
Variant X-13600018-A-G is Benign according to our data. Variant chrX-13600018-A-G is described in ClinVar as [Benign]. Clinvar id is 780681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.317 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.073 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
EGFL6 | NM_015507.4 | c.324A>G | p.Arg108= | synonymous_variant | 4/12 | ENST00000361306.6 | |
EGFL6 | NM_001167890.2 | c.324A>G | p.Arg108= | synonymous_variant | 4/12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
EGFL6 | ENST00000361306.6 | c.324A>G | p.Arg108= | synonymous_variant | 4/12 | 1 | NM_015507.4 | A2 | |
EGFL6 | ENST00000380602.3 | c.324A>G | p.Arg108= | synonymous_variant | 4/12 | 1 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0222 AC: 2474AN: 111620Hom.: 64 Cov.: 21 AF XY: 0.0195 AC XY: 660AN XY: 33802
GnomAD3 genomes
AF:
AC:
2474
AN:
111620
Hom.:
Cov.:
21
AF XY:
AC XY:
660
AN XY:
33802
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00727 AC: 1330AN: 183017Hom.: 31 AF XY: 0.00455 AC XY: 307AN XY: 67515
GnomAD3 exomes
AF:
AC:
1330
AN:
183017
Hom.:
AF XY:
AC XY:
307
AN XY:
67515
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00296 AC: 3244AN: 1096519Hom.: 66 Cov.: 29 AF XY: 0.00242 AC XY: 875AN XY: 361961
GnomAD4 exome
AF:
AC:
3244
AN:
1096519
Hom.:
Cov.:
29
AF XY:
AC XY:
875
AN XY:
361961
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0223 AC: 2490AN: 111672Hom.: 65 Cov.: 21 AF XY: 0.0198 AC XY: 671AN XY: 33864
GnomAD4 genome
AF:
AC:
2490
AN:
111672
Hom.:
Cov.:
21
AF XY:
AC XY:
671
AN XY:
33864
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 11, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at